Drug shortage: Heparin Sodium Injection (HEPARIN SODIUM, HEPARIN SODIUM IN SODIUM CHLORIDE)
FDA lists 8 presentations as Current. Availability: Unavailable (1), Limited Availability (3), Available (4). Reason: Other; Demand increase for the drug. Companies: Hospira, Inc., a Pfizer Company, B. Braun Medical Inc., Baxter Healthcare, Fresenius Kabi USA, LLC.
- Published by source
- 2017-11-14
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-27
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Heparin Sodium Injection HEPARIN SODIUM HEPARIN SODIUM IN SODIUM CHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: late Q4 2026; Manufacturing delays
- Estimated recovery: December 2026
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2017-11-14
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #891 | new | 2026-10-22 | ea1142e73415…eb7a4b | 2a5d59ddc0cd…342903 |
| #1216 | update | 2026-10-23 | 373a8c0b77c2…1d845d | bc53e1d5e124…a6f3b3 |
| #1407 | update | 2026-10-23 | f51966ffedf4…3a80c2 | 533ca60f6c28…33257c |
| #2179 | update | 2026-10-27 | 127fd3285c88…02566f | 93401cb67aaf…db04e2 |
Chain head: #2286 e212558e872c…954bc1